Literature DB >> 25257673

Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.

Yuko Masuzawa1, Masaaki Mori, Takuma Hara, Aya Inaba, Mari S Oba, Shumpei Yokota.   

Abstract

Although there are many reports on the resistance of Kawasaki disease (KD) to initial intravenous immunoglobulin (IVIg) therapy, risk factors for coronary artery lesions in such cases remain to be established. The objective of this study was to explore when additional therapies should be administered and to identify factors helpful for selecting a therapeutic option. Based on their written clinical records, we performed a retrospective review of KD patients who did not respond to initial IVIg therapy and who therefore then underwent plasma exchange (PE) therapy. This was a case-control study to compare the presence or absence of acute coronary lesions in patients treated by PE for IVIg-unresponsive KD at Yokohama City University Hospital or at Yokohama City University Medical Center. Fifteen of 44 patients had acute coronary artery lesions (CAL) correlating with high levels of white blood cells (WBC) (P = 0.045), D-dimer (P = 0.008), and fibrin/fibrinogen degradation products (P = 0.009) and lower levels of fibrinogen (P = 0.013) prior to PE therapy. There was a strong correlation between pre-PE levels of albumin and D-dimer (Pearson's correlation coefficient of 0.610). Multivariate analyses revealed that the odds ratio for CAL when D-dimer was ≥ 4.5 μg/mL was 25.06 (95% CI, 2.56-244.91, P = 0.006). D-dimer elevation and albumin decline in IVIg-unresponsive KD patients could be risk factors for acute CAL, suggesting the possibility that angitis has spread throughout the arterial system, as far as the coronary artery.
© 2014 The Authors. Therapeutic Apheresis and Dialysis © 2014 International Society for Apheresis.

Entities:  

Keywords:  Coronary artery lesions; Endothelial cells; Kawasaki disease; Plasma exchange; Vasculitis

Mesh:

Substances:

Year:  2014        PMID: 25257673     DOI: 10.1111/1744-9987.12235

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  4 in total

1.  Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.

Authors:  Aleksandra Stasiak; Elżbieta Smolewska
Journal:  Rheumatol Int       Date:  2019-03-22       Impact factor: 2.631

2.  Kawasaki disease in Sicily: clinical description and markers of disease severity.

Authors:  Maria Cristina Maggio; Giovanni Corsello; Eugenia Prinzi; Rolando Cimaz
Journal:  Ital J Pediatr       Date:  2016-11-02       Impact factor: 2.638

3.  Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan.

Authors:  Usha Sethuraman; Nirupama Kannikeswaran; Jocelyn Ang; Adam Singer; Jason Miller; Rita Haddad; Curt Stankovic
Journal:  Am J Emerg Med       Date:  2020-10-24       Impact factor: 4.093

4.  Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.

Authors:  Davinder Singh-Grewal; Ryan Lucas; Kristine McCarthy; Allen C Cheng; Nicholas Wood; Genevieve Ostring; Philip Britton; Nigel Crawford; David Burgner
Journal:  J Paediatr Child Health       Date:  2020-07-31       Impact factor: 1.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.